Suppressing Hunger with Superfoods: 9 Natural Appetite Suppressants for Weight Loss

The article discusses 9 superfoods that naturally suppress appetite for weight loss. These include oats, apples, chia seeds, almonds, lentils, green leafy vegetables, Greek yogurt, avocados, and eggs. Each of these foods is rich in fiber, protein, or healthy fats, which help keep you full for longer, regulate blood sugar, and support weight management goals.

The Food and Drug Administration (FDA) has approved Signos' glucose monitoring system for weight loss, marking a significant milestone in obesity management. This innovative tool, developed by Signos, leverages an AI platform and a Dexcom continuous glucose monitor (CGM) to provide personalized data and lifestyle recommendations for weight management. The system is designed to be accessible to any patient, regardless of Body Mass Index (BMI), and can be used in combination with other weight loss treatments such as GLP-1s or bariatric surgery.

The approval of Signos' system comes at a critical time, as the obesity epidemic continues to strain the U.S. healthcare system. With nearly 74% of Americans being overweight or obese, there is a pressing need for innovative solutions to help manage weight effectively. The system aims to make a substantial impact on this curve, offering a solution that is accessible to the average American.

The cost of Signos' system is currently $139 for a three-month plan and $129 for a six-month plan. While insurers do not currently cover the system for weight management, the plans are significantly more affordable than the monthly cost of GLP-1s in the U.S. Signos is actively working with health insurance companies and employers to secure coverage for the system.

The system uses a CGM to track glucose levels, with data wirelessly sent to Signos' app. This data, along with information on food intake and exercise levels, is used by the AI platform to provide personalized recommendations for weight management. The system aims to help users understand their body's response to specific foods and exercise patterns, enabling them to make informed behavioral changes for long-term weight management.

While the exact number of users currently utilizing the system is not disclosed, Signos has indicated that tens of thousands of people have tried it over time. The company has scaled up its CGM inventory and software capacity to handle increased demand following the FDA approval.

In conclusion, the FDA's approval of Signos' glucose monitoring system for weight loss represents a significant advancement in the field of obesity management. With its accessible pricing and broad applicability, the system has the potential to make a substantial impact on the obesity epidemic in the United States.

References:
[1] https://www.ainvest.com/news/fda-approves-signos-glucose-monitoring-system-weight-loss-2508/
[2] https://www.cnbc.com/2025/08/20/fda-approves-signos-glucose-monitoring-for-weight-loss.html
[3] https://www.signos.com/faqs